Selected research
Industry Research
Anti-inflammatory Drugs for Dental Industry Research Report 2026
Market perspective
The global Anti-inflammatory Drugs for Dental market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Anti-inflammatory Drugs for Dental market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Anti-inflammatory Drugs for Dental market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Anti-inflammatory Drugs for Dental market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Anti-inflammatory Drugs for Dental include Xiuzheng Pharmaceutical, Merck, Roche, Hutchison China MediTech, Bayer, Xttrium Laboratorie, Sunstar, Showa Yakuhin Kako and Septodont, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Anti-inflammatory Drugs for Dental market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Anti-inflammatory Drugs for Dental.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anti-inflammatory Drugs for Dental Market by Company
Xiuzheng Pharmaceutical
Merck
Roche
Hutchison China MediTech
Bayer
Xttrium Laboratorie
Sunstar
Showa Yakuhin Kako
Septodont
PerioChip
Mediwin Pharmaceuticals
JandJ
GSK
DenMat
Colgate-Palmolive
Bausch Health
Acteon
3M
Anti-inflammatory Drugs for Dental Segment by Type
OTC
Prescription
Anti-inflammatory Drugs for Dental Segment by Application
Dental Clinics
Hospitals
Pharmacies
Anti-inflammatory Drugs for Dental Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-inflammatory Drugs for Dental market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-inflammatory Drugs for Dental and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-inflammatory Drugs for Dental.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Anti-inflammatory Drugs for Dental companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- OTC
- Prescription
Applications
- Dental Clinics
- Hospitals
- Pharmacies
Companies covered
- Xiuzheng Pharmaceutical
- Merck
- Roche
- Hutchison China MediTech
- Bayer
- Xttrium Laboratorie
- Sunstar
- Showa Yakuhin Kako
- Septodont
- PerioChip
- Mediwin Pharmaceuticals
- JandJ
- GSK
- DenMat
- Colgate-Palmolive
- Bausch Health
- Acteon
- 3M
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Anti-inflammatory Drugs for Dental by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 OTC
- 2.2.3 Prescription
- 2.3 Anti-inflammatory Drugs for Dental by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Dental Clinics
- 2.3.3 Hospitals
- 2.3.4 Pharmacies
- 2.4 Assumptions and Limitations
3 Anti-inflammatory Drugs for Dental Breakdown Data by Type
- 3.1 Global Anti-inflammatory Drugs for Dental Historic Market Size by Type (2021-2026)
- 3.2 Global Anti-inflammatory Drugs for Dental Forecasted Market Size by Type (2027-2032)
4 Anti-inflammatory Drugs for Dental Breakdown Data by Application
- 4.1 Global Anti-inflammatory Drugs for Dental Historic Market Size by Application (2021-2026)
- 4.2 Global Anti-inflammatory Drugs for Dental Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Anti-inflammatory Drugs for Dental Market Perspective (2021-2032)
- 5.2 Global Anti-inflammatory Drugs for Dental Growth Trends by Region
- 5.2.1 Global Anti-inflammatory Drugs for Dental Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Anti-inflammatory Drugs for Dental Historic Market Size by Region (2021-2026)
- 5.2.3 Anti-inflammatory Drugs for Dental Forecasted Market Size by Region (2027-2032)
- 5.3 Anti-inflammatory Drugs for Dental Market Dynamics
- 5.3.1 Anti-inflammatory Drugs for Dental Industry Trends
- 5.3.2 Anti-inflammatory Drugs for Dental Market Drivers
- 5.3.3 Anti-inflammatory Drugs for Dental Market Challenges
- 5.3.4 Anti-inflammatory Drugs for Dental Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Anti-inflammatory Drugs for Dental Players by Revenue
- 6.1.1 Global Top Anti-inflammatory Drugs for Dental Players by Revenue (2021-2026)
- 6.1.2 Global Anti-inflammatory Drugs for Dental Revenue Market Share by Players (2021-2026)
- 6.2 Global Anti-inflammatory Drugs for Dental Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Anti-inflammatory Drugs for Dental Head Office and Area Served
- 6.4 Global Anti-inflammatory Drugs for Dental Players, Product Type & Application
- 6.5 Global Anti-inflammatory Drugs for Dental Manufacturers Established Date
- 6.6 Global Anti-inflammatory Drugs for Dental Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Anti-inflammatory Drugs for Dental Market Size (2021-2032)
- 7.2 North America Anti-inflammatory Drugs for Dental Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Anti-inflammatory Drugs for Dental Market Size by Country (2021-2026)
- 7.4 North America Anti-inflammatory Drugs for Dental Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Anti-inflammatory Drugs for Dental Market Size (2021-2032)
- 8.2 Europe Anti-inflammatory Drugs for Dental Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Anti-inflammatory Drugs for Dental Market Size by Country (2021-2026)
- 8.4 Europe Anti-inflammatory Drugs for Dental Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Anti-inflammatory Drugs for Dental Market Size (2021-2032)
- 9.2 Asia-Pacific Anti-inflammatory Drugs for Dental Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Anti-inflammatory Drugs for Dental Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Anti-inflammatory Drugs for Dental Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Anti-inflammatory Drugs for Dental Market Size (2021-2032)
- 10.2 South America Anti-inflammatory Drugs for Dental Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Anti-inflammatory Drugs for Dental Market Size by Country (2021-2026)
- 10.4 South America Anti-inflammatory Drugs for Dental Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Anti-inflammatory Drugs for Dental Market Size (2021-2032)
- 11.2 Middle East & Africa Anti-inflammatory Drugs for Dental Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Anti-inflammatory Drugs for Dental Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Anti-inflammatory Drugs for Dental Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Xiuzheng Pharmaceutical
- 12.1.1 Xiuzheng Pharmaceutical Company Information
- 12.1.2 Xiuzheng Pharmaceutical Business Overview
- 12.1.3 Xiuzheng Pharmaceutical Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.1.4 Xiuzheng Pharmaceutical Anti-inflammatory Drugs for Dental Product Portfolio
- 12.1.5 Xiuzheng Pharmaceutical Recent Developments
- 12.2 Merck
- 12.2.1 Merck Company Information
- 12.2.2 Merck Business Overview
- 12.2.3 Merck Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.2.4 Merck Anti-inflammatory Drugs for Dental Product Portfolio
- 12.2.5 Merck Recent Developments
- 12.3 Roche
- 12.3.1 Roche Company Information
- 12.3.2 Roche Business Overview
- 12.3.3 Roche Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.3.4 Roche Anti-inflammatory Drugs for Dental Product Portfolio
- 12.3.5 Roche Recent Developments
- 12.4 Hutchison China MediTech
- 12.4.1 Hutchison China MediTech Company Information
- 12.4.2 Hutchison China MediTech Business Overview
- 12.4.3 Hutchison China MediTech Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.4.4 Hutchison China MediTech Anti-inflammatory Drugs for Dental Product Portfolio
- 12.4.5 Hutchison China MediTech Recent Developments
- 12.5 Bayer
- 12.5.1 Bayer Company Information
- 12.5.2 Bayer Business Overview
- 12.5.3 Bayer Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.5.4 Bayer Anti-inflammatory Drugs for Dental Product Portfolio
- 12.5.5 Bayer Recent Developments
- 12.6 Xttrium Laboratorie
- 12.6.1 Xttrium Laboratorie Company Information
- 12.6.2 Xttrium Laboratorie Business Overview
- 12.6.3 Xttrium Laboratorie Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.6.4 Xttrium Laboratorie Anti-inflammatory Drugs for Dental Product Portfolio
- 12.6.5 Xttrium Laboratorie Recent Developments
- 12.7 Sunstar
- 12.7.1 Sunstar Company Information
- 12.7.2 Sunstar Business Overview
- 12.7.3 Sunstar Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.7.4 Sunstar Anti-inflammatory Drugs for Dental Product Portfolio
- 12.7.5 Sunstar Recent Developments
- 12.8 Showa Yakuhin Kako
- 12.8.1 Showa Yakuhin Kako Company Information
- 12.8.2 Showa Yakuhin Kako Business Overview
- 12.8.3 Showa Yakuhin Kako Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.8.4 Showa Yakuhin Kako Anti-inflammatory Drugs for Dental Product Portfolio
- 12.8.5 Showa Yakuhin Kako Recent Developments
- 12.9 Septodont
- 12.9.1 Septodont Company Information
- 12.9.2 Septodont Business Overview
- 12.9.3 Septodont Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.9.4 Septodont Anti-inflammatory Drugs for Dental Product Portfolio
- 12.9.5 Septodont Recent Developments
- 12.10 PerioChip
- 12.10.1 PerioChip Company Information
- 12.10.2 PerioChip Business Overview
- 12.10.3 PerioChip Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.10.4 PerioChip Anti-inflammatory Drugs for Dental Product Portfolio
- 12.10.5 PerioChip Recent Developments
- 12.11 Mediwin Pharmaceuticals
- 12.11.1 Mediwin Pharmaceuticals Company Information
- 12.11.2 Mediwin Pharmaceuticals Business Overview
- 12.11.3 Mediwin Pharmaceuticals Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.11.4 Mediwin Pharmaceuticals Anti-inflammatory Drugs for Dental Product Portfolio
- 12.11.5 Mediwin Pharmaceuticals Recent Developments
- 12.12 JandJ
- 12.12.1 JandJ Company Information
- 12.12.2 JandJ Business Overview
- 12.12.3 JandJ Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.12.4 JandJ Anti-inflammatory Drugs for Dental Product Portfolio
- 12.12.5 JandJ Recent Developments
- 12.13 GSK
- 12.13.1 GSK Company Information
- 12.13.2 GSK Business Overview
- 12.13.3 GSK Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.13.4 GSK Anti-inflammatory Drugs for Dental Product Portfolio
- 12.13.5 GSK Recent Developments
- 12.14 DenMat
- 12.14.1 DenMat Company Information
- 12.14.2 DenMat Business Overview
- 12.14.3 DenMat Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.14.4 DenMat Anti-inflammatory Drugs for Dental Product Portfolio
- 12.14.5 DenMat Recent Developments
- 12.15 Colgate-Palmolive
- 12.15.1 Colgate-Palmolive Company Information
- 12.15.2 Colgate-Palmolive Business Overview
- 12.15.3 Colgate-Palmolive Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.15.4 Colgate-Palmolive Anti-inflammatory Drugs for Dental Product Portfolio
- 12.15.5 Colgate-Palmolive Recent Developments
- 12.16 Bausch Health
- 12.16.1 Bausch Health Company Information
- 12.16.2 Bausch Health Business Overview
- 12.16.3 Bausch Health Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.16.4 Bausch Health Anti-inflammatory Drugs for Dental Product Portfolio
- 12.16.5 Bausch Health Recent Developments
- 12.17 Acteon
- 12.17.1 Acteon Company Information
- 12.17.2 Acteon Business Overview
- 12.17.3 Acteon Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.17.4 Acteon Anti-inflammatory Drugs for Dental Product Portfolio
- 12.17.5 Acteon Recent Developments
- 12.18 3M
- 12.18.1 3M Company Information
- 12.18.2 3M Business Overview
- 12.18.3 3M Revenue in Anti-inflammatory Drugs for Dental Business (2021-2026)
- 12.18.4 3M Anti-inflammatory Drugs for Dental Product Portfolio
- 12.18.5 3M Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst